Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Scott Christie

Psychiatry Mount Pleasant, SC Medical Doctor

NPI 1578655205 CMS profile 26474

1001 Anna Knapp Blvd, Mount Pleasant, SC 29464

Open in the dashboard

General payments

$14,478

127 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Scott Christie of Mount Pleasant, SC is reported in the CMS Open Payments database as having received $14,478 across 127 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $800 20
2022 General $508 9
2020 General $1,469 17
2019 General $11,702 81

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Scott Christie
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Scott Christie were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Scott Christie Psychiatry median Middle half National median
2019 $11,702 $184 $59–$605 $163
2020 $1,469 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $508 $153 $50–$590 $149
2023 $800 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Janssen Pharmaceuticals, Inc $11,842 51 payments
  2. Sunovion Pharmaceuticals Inc. $484 12 payments
  3. Alkermes, Inc. $436 9 payments
  4. Teva Pharmaceuticals USA, Inc. $425 14 payments
  5. Neurocrine Biosciences, Inc. $328 8 payments
  6. Otsuka America Pharmaceutical, Inc. $282 7 payments
  7. Otsuka Pharmaceutical Development & Commercialization, Inc. $259 7 payments
  8. Idorsia Pharmaceuticals US Inc $184 4 payments
  9. Indivior Inc. $101 6 payments
  10. Vanda Pharmaceuticals Inc. $83 5 payments
  11. Other $54 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,110 9 payments
  2. Food and Beverage $4,098 116 payments
  3. Travel and Lodging $271 2 payments
Products named General payments · program years 2019–2023
  1. INVEGA SUSTENNA $11,445 43 payments
  2. INVEGA TRINZA $10,287 22 payments
  3. LATUDA $484 12 payments
  4. AUSTEDO $425 14 payments
  5. SPRAVATO $424 10 payments
  6. ARISTADA INITIO $289 6 payments
  7. ARISTADA Cns $289 6 payments
  8. ARISTADA Cns $289 6 payments
  9. ARISTADA Cns $289 6 payments
  10. ARISTADA Cns $289 6 payments
  11. Other $1,702 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

127 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record